NO752675L - - Google Patents

Info

Publication number
NO752675L
NO752675L NO752675A NO752675A NO752675L NO 752675 L NO752675 L NO 752675L NO 752675 A NO752675 A NO 752675A NO 752675 A NO752675 A NO 752675A NO 752675 L NO752675 L NO 752675L
Authority
NO
Norway
Application number
NO752675A
Other languages
Norwegian (no)
Other versions
NO150117B (no
NO150117C (no
Inventor
C Gandolfi
G Doria
R Pellegata
M M Usardi
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NO752675L publication Critical patent/NO752675L/no
Publication of NO150117B publication Critical patent/NO150117B/no
Publication of NO150117C publication Critical patent/NO150117C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO752675A 1974-09-17 1975-07-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater NO150117C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2733374 1974-09-17

Publications (3)

Publication Number Publication Date
NO752675L true NO752675L (US20050065096A1-20050324-C00039.png) 1976-03-18
NO150117B NO150117B (no) 1984-05-14
NO150117C NO150117C (no) 1984-08-22

Family

ID=11221442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752675A NO150117C (no) 1974-09-17 1975-07-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive prostaglandinderivater

Country Status (20)

Country Link
US (1) US4041064A (US20050065096A1-20050324-C00039.png)
JP (1) JPS5929075B2 (US20050065096A1-20050324-C00039.png)
BE (1) BE832891A (US20050065096A1-20050324-C00039.png)
CA (1) CA1098126A (US20050065096A1-20050324-C00039.png)
CH (2) CH614936A5 (US20050065096A1-20050324-C00039.png)
CS (1) CS191274B2 (US20050065096A1-20050324-C00039.png)
DE (1) DE2537406A1 (US20050065096A1-20050324-C00039.png)
DK (1) DK348575A (US20050065096A1-20050324-C00039.png)
FI (1) FI752303A (US20050065096A1-20050324-C00039.png)
FR (1) FR2313028A1 (US20050065096A1-20050324-C00039.png)
GB (2) GB1514543A (US20050065096A1-20050324-C00039.png)
HK (1) HK4079A (US20050065096A1-20050324-C00039.png)
HU (1) HU175345B (US20050065096A1-20050324-C00039.png)
IL (1) IL48027A (US20050065096A1-20050324-C00039.png)
MY (1) MY8000016A (US20050065096A1-20050324-C00039.png)
NL (1) NL7510191A (US20050065096A1-20050324-C00039.png)
NO (1) NO150117C (US20050065096A1-20050324-C00039.png)
SE (2) SE423992B (US20050065096A1-20050324-C00039.png)
SU (1) SU942588A3 (US20050065096A1-20050324-C00039.png)
ZA (1) ZA755310B (US20050065096A1-20050324-C00039.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220759A (en) * 1975-03-14 1980-09-02 Carlo Erba S.P.A. 13,14-Dehydro-11-deoxy-prostaglandins and process for their preparation
HU178202B (en) * 1977-09-26 1982-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new,optically active and racemic bicyclic acetals and merkaptals
US20090287003A1 (en) * 2005-09-29 2009-11-19 Jiang Xing Chen Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones

Also Published As

Publication number Publication date
NL7510191A (nl) 1976-03-19
SE7808849L (sv) 1978-08-22
IL48027A0 (en) 1975-11-25
GB1514543A (en) 1978-06-14
CA1098126A (en) 1981-03-24
FR2313028A1 (fr) 1976-12-31
JPS5929075B2 (ja) 1984-07-18
CH617424A5 (US20050065096A1-20050324-C00039.png) 1980-05-30
AU8350075A (en) 1977-02-03
SE7509607L (sv) 1976-03-18
NO150117B (no) 1984-05-14
DK348575A (da) 1976-03-18
HU175345B (hu) 1980-07-28
SU942588A3 (ru) 1982-07-07
GB1514542A (en) 1978-06-14
JPS5143745A (en) 1976-04-14
US4041064A (en) 1977-08-09
FR2313028B1 (US20050065096A1-20050324-C00039.png) 1980-05-30
FI752303A (US20050065096A1-20050324-C00039.png) 1976-03-18
SE423992B (sv) 1982-06-21
MY8000016A (en) 1980-12-31
IL48027A (en) 1980-03-31
NO150117C (no) 1984-08-22
BE832891A (fr) 1976-03-01
SE427556B (sv) 1983-04-18
HK4079A (en) 1979-01-26
CS191274B2 (en) 1979-06-29
ZA755310B (en) 1977-04-27
CH614936A5 (US20050065096A1-20050324-C00039.png) 1979-12-28
DE2537406A1 (de) 1976-08-12

Similar Documents

Publication Publication Date Title
FR2267358A1 (US20050065096A1-20050324-C00039.png)
FR2260912A1 (US20050065096A1-20050324-C00039.png)
FR2260211A1 (US20050065096A1-20050324-C00039.png)
FR2293216B1 (US20050065096A1-20050324-C00039.png)
FI751887A (US20050065096A1-20050324-C00039.png)
FR2288530B3 (US20050065096A1-20050324-C00039.png)
FR2313028B1 (US20050065096A1-20050324-C00039.png)
FI750998A (US20050065096A1-20050324-C00039.png)
FR2274050B3 (US20050065096A1-20050324-C00039.png)
FI753377A (US20050065096A1-20050324-C00039.png)
FI51168B (US20050065096A1-20050324-C00039.png)
CS174533B1 (US20050065096A1-20050324-C00039.png)
CS165407B1 (US20050065096A1-20050324-C00039.png)
BG19867A1 (US20050065096A1-20050324-C00039.png)
CH597161A5 (US20050065096A1-20050324-C00039.png)
BG20237A1 (US20050065096A1-20050324-C00039.png)
BG20146A1 (US20050065096A1-20050324-C00039.png)
BG20001A1 (US20050065096A1-20050324-C00039.png)
BG20430A1 (US20050065096A1-20050324-C00039.png)
AU480469A (US20050065096A1-20050324-C00039.png)
BG20475A1 (US20050065096A1-20050324-C00039.png)
BG21080A1 (US20050065096A1-20050324-C00039.png)
BG20501A1 (US20050065096A1-20050324-C00039.png)
DD111588A1 (US20050065096A1-20050324-C00039.png)
BG19729A1 (US20050065096A1-20050324-C00039.png)